In recent years the determined efforts of numerous investigators and the dedicated participation of patients, families and clinicians have led to the mapping and identification of numerous genetic loci involved in inherited glomerular disease and the functional characterization of their protein products. This information has generated important insights into the cell–cell and cell–matrix interactions required for normal glomerular structure and function, and the mechanisms by which genetically programmed disruptions in these interactions produce disease phenotypes.